Global Veterinary Ophthalmic Drugs Market Size & Outlook

The global veterinary ophthalmic drugs market size was estimated at USD 1,947.0 million in 2024 and is projected to reach USD 3,599.8 million by 2033, growing at a CAGR of 7% from 2025 to 2033.
Revenue, 2024 (US$M)
$1,947.0
Forecast, 2033 (US$M)
$3,599.8
CAGR, 2025 - 2033
7%
Report Coverage
Worldwide

Global veterinary ophthalmic drugs market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Global veterinary ophthalmic drugs market highlights

  • The global veterinary ophthalmic drugs market generated a revenue of USD 1,947.0 million in 2024 and is expected to reach USD 3,599.8 million by 2033.
  • The market is expected to grow at a CAGR (2025 - 2033) of 7% by 2033.
  • In terms of segment, lubricants / artificial tears accounted for a revenue of USD 543.6 million in 2024.
  • Lubricants / Artificial Tears is the most lucrative drug segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2033.

Global data book summary

Market revenue in 2024USD 1,947.0 million
Market revenue in 2033USD 3,599.8 million
Growth rate7% (CAGR from 2025 to 2033)
Largest segmentLubricants / artificial tears
Fastest growing segmentLubricants / Artificial Tears
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAntibiotics, NSAIDs, Corticosteroids, Lubricants / Artificial Tears, Analgesics / Pain Relievers, Other Drugs

Other key industry trends

  • In terms of revenue, the North America accounted for 41.2% of the global veterinary ophthalmic drugs market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, India is the fastest growing regional market and is projected to reach USD 188.8 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Ophthalmic Drugs Market Companies

Name Profile # Employees HQ Website
iMEDHealth View profile 11-50 East Stroudsburg, Pennsylvania, United States, North America http://imedhealth.us
Sandoz Group AG ADR View profile - - -
Ceva Santé Animale View profile 5001-10000 Libourne, Aquitaine, France, Europe https://www.ceva.us
Norbrook View profile 1001-5000 Newry, Newry and Mourne, United Kingdom, Europe http://www.norbrook.com
Dechra Pharmaceuticals View profile 501-1000 Northwich, Cheshire, United Kingdom, Europe http://www.dechra.com
Elanco Animal Health Inc View profile 9800 2500 Innovation Way, Greenfield, IN, United States, 46140 https://www.elanco.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com
Bausch & Lomb Corp View profile 13300 520 Applewood Crescent, Vaughan, ON, Canada, L4K 4B4 https://www.bausch.com

Global veterinary ophthalmic drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary ophthalmic drugs market will help companies and investors design strategic landscapes.


Lubricants / artificial tears was the largest segment with a revenue share of 27.92% in 2024. Horizon Databook has segmented the Global veterinary ophthalmic drugs market based on antibiotics, nsaids, corticosteroids, lubricants / artificial tears, analgesics / pain relievers, other drugs covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Veterinary Ophthalmic Drugs Drug Outlook (Revenue, USD Million, 2021-2033)
    • Antibiotics
    • NSAIDs
    • Corticosteroids
    • Lubricants / Artificial Tears
    • Analgesics / Pain Relievers
    • Other Drugs
  • Global Veterinary Ophthalmic Drugs Animal Type Outlook (Revenue, USD Million, 2021-2033)
    • Canine
    • Feline
    • Equine
    • Bovine
    • Other Animal Type
  • Global Veterinary Ophthalmic Drugs Indication Outlook (Revenue, USD Million, 2021-2033)
    • Eyelid Abnormalities
    • Cataract
    • Glaucoma
    • Retinal Complications
    • Uveitis
    • Conjunctivitis
    • Corneal Complications
    • Others Indication
  • Global Veterinary Ophthalmic Drugs Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
    • Veterinary Hospitals & Clinics
    • Pet Specialty Stores
    • E-Commerce
    • Others Distribution Channel

Reasons to subscribe to Global veterinary ophthalmic drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global veterinary ophthalmic drugs market databook

  • Our clientele includes a mix of veterinary ophthalmic drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global veterinary ophthalmic drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global veterinary ophthalmic drugs market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global veterinary ophthalmic drugs market size, by regions, 2021-2033 (US$M)

Top 10 countries: Veterinary ophthalmic drugs market size, 2024 (US$M)

Global veterinary ophthalmic drugs market share, by drug, 2024 & 2033 (%, US$M)

Veterinary ophthalmic drugs market: Opportunity assessment by country

Global veterinary ophthalmic drugs market, by region, 2024 (US$M)

Global veterinary ophthalmic drugs market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online